Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis
- PMID: 37899440
- PMCID: PMC10614317
- DOI: 10.1186/s13075-023-03196-3
Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis
Abstract
Background: Cardiovascular (CV) risk estimation calculators for the general population underperform in patients with rheumatoid arthritis (RA). The purpose of this study was to identify relevant protein biomarkers that could be added to traditional CV risk calculators to improve the capacity of coronary artery calcification (CAC) prediction in individuals with RA. In a second step, we quantify the improvement of this prediction of CAC when these circulating biomarkers are added to standard risk scores.
Methods: A panel of 141 serum and plasma proteins, which represent a broad base of both CV and RA biology, were evaluated and prioritized as candidate biomarkers. Of these, 39 proteins were selected and measured by commercial ELISA or quantitative mass spectroscopy in 561 individuals with RA in whom a measure of CAC and frozen sera were available. The patients were randomly split 50:50 into a training/validation cohort. Discrimination (using area under the receiver operator characteristic curves) and re-classification (through net reclassification improvement and integrated discrimination improvement calculation) analyses were performed first in the training cohort and replicated in the validation cohort, to estimate the increase in prediction accuracy for CAC using the ACA/AHA (American College of Cardiology and the American Heart Association) score with, compared to without, addition of these circulating biomarkers.
Results: The model containing ACC/AHA score plus cytokines (osteopontin, cartilage glycoprotein-39, cystatin C, and chemokine (C-C motif) ligand 18) and plus quantitative mass spectroscopy biomarkers (serpin D1, paraoxonase, and clusterin) had a statistically significant positive net reclassifications index and integrated discrimination improvement for the prediction of CAC, using ACC/AHA score without any biomarkers as the reference category. These results were confirmed in the validation cohort.
Conclusion: In this exploratory analysis, the addition of several circulating CV and RA biomarkers to a standard CV risk calculator yielded significant improvements in discrimination and reclassification for the presence of CAC in individuals with RA.
Keywords: Cardiovascular risk; Coronary artery calcification; Rheumatoid arthritis.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.Arthritis Rheumatol. 2015 Feb;67(2):381-5. doi: 10.1002/art.38944. Arthritis Rheumatol. 2015. PMID: 25371313 Free PMC article.
-
Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator.J Rheumatol. 2019 Feb;46(2):130-137. doi: 10.3899/jrheum.171008. Epub 2018 Oct 1. J Rheumatol. 2019. PMID: 30275258
-
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.Rheumatology (Oxford). 2017 Jul 1;56(7):1102-1110. doi: 10.1093/rheumatology/kex038. Rheumatology (Oxford). 2017. PMID: 28339992 Free PMC article.
-
Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines.Prog Cardiovasc Dis. 2019 Sep-Oct;62(5):423-430. doi: 10.1016/j.pcad.2019.10.007. Epub 2019 Nov 9. Prog Cardiovasc Dis. 2019. PMID: 31715194 Review.
-
Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?Atherosclerosis. 2017 Feb;257:279-287. doi: 10.1016/j.atherosclerosis.2017.01.007. Epub 2017 Jan 13. Atherosclerosis. 2017. PMID: 28126319 Review.
Cited by
-
Significance of neutrophil extracellular traps-related gene in the diagnosis and classification of atherosclerosis.Apoptosis. 2024 Jun;29(5-6):605-619. doi: 10.1007/s10495-023-01923-4. Epub 2024 Feb 17. Apoptosis. 2024. PMID: 38367202
-
Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge.Biomedicines. 2024 Jul 19;12(7):1608. doi: 10.3390/biomedicines12071608. Biomedicines. 2024. PMID: 39062180 Free PMC article. Review.
-
Analysis of risk factors and the predictive value of a nomogram model for coronary heart disease in patients with rheumatoid arthritis.Front Cardiovasc Med. 2025 Jun 9;12:1558012. doi: 10.3389/fcvm.2025.1558012. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40552192 Free PMC article.
References
-
- Rho YH, Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, et al. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:1473–1480. doi: 10.1002/acr.20237. - DOI - PMC - PubMed
-
- Kawai VK, Chung CP, Solus JF, Oeser A, Raggi P, Stein CM. Brief report: the ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores. Arthritis Rheumatol. 2015;67:381–385. doi: 10.1002/art.38944. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials